Investigator Initiated Trial of Galcanezumab Treatment in Alzheimer's Disease

Clinical trial NCT07323927 · RECRUITING

Trial details

NCT number: NCT07323927
Sponsor: Xuanwu Hospital, Beijing
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2025-08-01
Primary completion: 2027-01-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.